Inducing remission in ANCA-positive vasculitis: time to RAVE? Richard A. Watts 1 Nature Reviews Rheumatology volume 6 , pages 127–128 ( 2010 ) Cite this article ...
Children with AAV and kidney disease face increased risks for long-term renal damage at 1 year, despite the majority achieving inactive renal disease by this time.
Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...
Hosted on MSN1mon
I almost died after giving birth. 19 years later, my son and the son of the doctor who saved my life are dorm mates in college.Eventually, I was diagnosed with a rare autoimmune disease: ANCA-positive vasculitis. It had been triggered by childbirth. Doctors stabilized me enough to send me home, but I was very sick for the ...
Well, we are very excited that we have multiple development in the study of treatment of vasculitis, and this is all because ...
RENAL-F02 is an ongoing Phase 2 study in Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis (AAV) with Rapidly Progressive Glomerulonephritis (RPGN) (NCT06047171), where 26 patients ...
and renal limited vasculitis, WG/GPA has been demonstrated to have a strong association with antineutrophil cytoplasm antibody (ANCA), although not all cases may be accompanied with a positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback